White Matter Alterations in the Brains of Patients with Active, Remitted, and Cured Cushing Syndrome: A DTI Study

References

1. 1.↵
   2. Newell-Price J

   . Cushing's syndrome. Clin Med 2008;8:204–08

   FREE Full Text
2. 2.↵
   2. Hatipoglu BA

   . Cushing's syndrome. J Surg Oncol 2012;106:565–71

   CrossRefPubMed
3. 3.↵
   2. Guaraldi F,
   3. Salvatori R

   . Cushing syndrome: maybe not so uncommon of an endocrine disease. J Am Board Fam Med 2012;25:199–208

   Abstract/FREE Full Text
4. 4.↵
   2. Sapolsky RM,
   3. Krey LC,
   4. McEwen BS

   . The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev 1986;7:284–301

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Riddle DR

   2. Goosens KA,
   3. Sapolsky RM

   . Stress and glucocorticoid contributions to normal and pathological aging. In Riddle DR, ed. Brain Aging: Models, Methods, and Mechanisms. Boca Raton: CRC Press; 2007:305–22
6. 6.↵
   2. Bohn MC,
   3. Friedrich VL Jr.

   . Recovery of myelination in rat optic nerve after developmental retardation by cortisol. J Neurosci 1982;2:1292–98

   Abstract
7. 7.↵
   2. Alonso G

   . Prolonged corticosterone treatment of adult rats inhibits the proliferation of oligodendrocyte progenitors present throughout white and gray matter regions of the brain. Glia 2000;31:219–31

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Miyata S,
   3. Koyama Y,
   4. Takemoto K, et al

   . Plasma corticosterone activates SGK1 and induces morphological changes in oligodendrocytes in corpus callosum. PLoS One 2011;6:e19859

   CrossRefPubMed
9. 9.↵
   2. Fallo F,
   3. Sonino N

   . Should we evaluate for cardiovascular disease in patients with Cushing's syndrome? Clin Endocrinol 2009;71:768–71

   CrossRefPubMed
10. 10.↵
    2. Aulinas A,
    3. Valassi E,
    4. Webb SM

    . Prognosis of patients treated for Cushing syndrome. Endocrinol Nutr 2014;61:52–61

    CrossRefPubMed
11. 11.↵
    2. Miljic P,
    3. Miljic D,
    4. Cain JW, et al

    . Pathogenesis of vascular complications in Cushing's syndrome. Hormones (Athens) 2012;11:21–30

    PubMed
12. 12.↵
    2. Trethowan WH,
    3. Cobb S

    . Neuropsychiatric aspects of Cushing's syndrome. AMA Arch Neurol Psychiatry 1952;67:283–309

    CrossRefPubMed
13. 13.↵
    2. Cope O,
    3. Raker JW

    . Cushing's disease: the surgical experience in the care of 46 cases. N Engl J Med 1955;253:119–27

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Starkman MN,
    3. Gebarski SS,
    4. Berent S, et al

    . Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol Psychiatry 1992;32:756–65

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Simmons NE,
    3. Do HM,
    4. Lipper MH, et al

    . Cerebral atrophy in Cushing's disease. Surg Neurol 2000;53:72–76

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Resmini E,
    3. Santos A,
    4. Gómez-Anson B, et al

    . Verbal and visual memory performance and hippocampal volumes, measured by 3-Tesla magnetic resonance imaging, in patients with Cushing's syndrome. J Clin Endocrinol Metab 2012;97:663–71

    CrossRefPubMedWeb of Science
17. 17.↵
    2. van der Werff SJ,
    3. Andela CD,
    4. Nienke Pannekoek J, et al

    . Widespread reductions of white matter integrity in patients with long-term remissions of Cushing's disease. Neuroimage Clin 2014;4:659–67

    CrossRefPubMed
18. 18.↵
    2. Johansen-Berg H,
    3. Rushworth MF

    . Using diffusion imaging to study human connectional anatomy. Annu Rev Neurosci 2009;32:75–94

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Le Bihan D,
    3. Breton E,
    4. Lallemand D, et al

    . MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986;161:401–07

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Le Bihan D

    . Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci 2003;4:469–80

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Alexander AL,
    3. Lee JE,
    4. Lazar M, et al

    . Diffusion tensor imaging of the brain. Neurotherapeutics 2007;4:316–29

    CrossRefPubMedWeb of Science
22. 22.↵
    2. Budde MD,
    3. Xie M,
    4. Cross AH, et al

    . Axial diffusivity is the primary correlate of axonal injury in the experimental autoimmune encephalomyelitis spinal cord: a quantitative pixelwise analysis. J Neurosci 2009;29:2805–13

    Abstract/FREE Full Text
23. 23.↵
    2. Hsu JL,
    3. Chen YL,
    4. Leu JG, et al

    . Microstructural white matter abnormalities in type 2 diabetes mellitus: a diffusion tensor imaging study. Neuroimage 2012;59:1098–105

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Smith SM,
    3. Jenkinson M,
    4. Woolrich MW, et al

    . Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23(suppl 1):S208–19

    CrossRefPubMedWeb of Science
25. 25.↵
    2. Smith SM

    . Fast robust automated brain extraction. Hum Brain Mapp 2002;17:143–55

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Smith SM,
    3. Jenkinson M,
    4. Johansen-Berg H, et al

    . Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006;31:1487–505

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Horsfield MA,
    3. Jones DK

    . Applications of diffusion-weighted and diffusion tensor MRI to white matter diseases: a review. NMR Biomed 2002;15:570–77

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Beaulieu C

    . The basis of anisotropic water diffusion in the nervous system: a technical review. NMR Biomed 2002;15:435–55

    CrossRefPubMedWeb of Science
29. 29.↵
    2. Song SK,
    3. Yoshino J,
    4. Le TQ, et al

    . Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 2005;26:132–40

    CrossRefPubMedWeb of Science
30. 30.↵
    2. Wheeler-Kingshott CA,
    3. Cercignani M

    . About “axial” and “radial” diffusivities. Magn Res Med 2009;61:1255–60

    CrossRefPubMedWeb of Science
31. 31.↵
    2. Jones DK,
    3. Knösche TR,
    4. Turner R

    . White matter integrity, fiber count, and other fallacies: the do's and don'ts of diffusion MRI. Neuroimage 2013;73:239–54

    CrossRefPubMedWeb of Science
32. 32.↵
    2. Minati L,
    3. Grisoli M,
    4. Bruzzone MG

    . MR spectroscopy, functional MRI, and diffusion-tensor imaging in the aging brain: a conceptual review. J Geriatr Psychiatry Neurol 2007;20:3–21

    Abstract/FREE Full Text
33. 33.↵
    2. Burzynska AZ,
    3. Preuschhof C,
    4. Bäckman L, et al

    . Age-related differences in white matter microstructure: region-specific patterns of diffusivity. Neuroimage 2010;49:2104–12

    CrossRefPubMedWeb of Science
34. 34.↵
    2. Bourdeau I,
    3. Bard C,
    4. Noël B, et al

    . Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism. J Clin Endocrinol Metab 2002;87:1949–54

    CrossRefPubMedWeb of Science
35. 35.↵
    2. Starkman MN,
    3. Giordani B,
    4. Gebarski SS, et al

    . Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease. Biol Psychiatry 1999;46:1595–602

    CrossRefPubMedWeb of Science
36. 36.↵
    2. Resmini E,
    3. Santos A,
    4. Gómez-Anson B, et al

    . Hippocampal dysfunction in cured Cushing's syndrome patients, detected by (1) H-MR-spectroscopy. Clin Endocrinol (Oxf) 2013;79:700–07

    PubMed
37. 37.↵
    2. Sorrells ,
    3. Sapolsky RM

    . An inflammatory review of glucocorticoid actions in the CNS. Brain Behav Immun 2007;21:259–72

    CrossRefPubMed
38. 38.↵
    2. Barahona MJ,
    3. Sucunza N,
    4. Resmini E, et al

    . Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome. J Clin Endocrinol Metab 2009;94:3365–71

    CrossRefPubMedWeb of Science